Skip to main content

Coronavirus Antibody Tests: Can You Trust the Results?

By Commentary, COVID-19, In the News
Contributed by Edwin Monuki, MD, PhD, Warren L. Bostick Professor and Chair of Pathology and Laboratory Medicine at UC Irvine A recent article in the The New York Times focuses on an issue of grave concern among US health care providers - the flood of unapproved “lateral flow” tests for detecting COVID-19 antibodies. This flood resulted from an FDA decision to allow antibody testing without their usual approval process in order to accelerate the national response to COVID-19. Unfortunately (and not surprisingly), this also resulted in an antibody testing market that one interviewee in the NYT article called the “Wild West”.…
Read More

FDA Gives Emergency Authorization For Some COVID-19 Patients To Use Remdesivir

By COVID-19, In the News
NPR reports May 1, 2020 4:22 PM ET - The Food and Drug Administration has given emergency use authorization to the antiviral drug remdesivir to treat hospitalized patients with the coronavirus, President Trump on Friday told reporters at the White House. Gilead CEO Daniel O'Day said remdesivir maker Gilead Sciences is donating 1.5 million vials of the drug and will work with the federal government to distribute it to patients in need...
Read More

VIDEO: Alzheimer’s disease, clinical trials, and COVID-19 with Dr. Daniel Gillen

By Commentary, Community Events, COVID-19
ASK THE DOC! UCI MIND Facebook LIVE Video Series This monthly series features short talks and Q&A with experts from the University of California, Irvine Institute for Memory Impairments and Neurological Disorders (UCI MIND), 1 of 32 congressionally designated Alzheimer’s Disease Research Centers in the nation. Join UCI MIND on Facebook (@UCIrvineMIND) to learn about advances in research to improve Alzheimer’s disease diagnosis, treatment, and prevention. Alzheimer's disease, clinical trials, and COVID-19   About the Speaker: Dr. Gillen received his PhD in Biostatistics from the University of Washington and leads the Data Management and Statistics Core for UCI MIND’s NIH-designated…
Read More

CDC Adds Six New COVID-19 Symptoms

By Commentary, COVID-19
Over the weekend, the CDC added six new coronavirus symptoms to its list. The new symptoms include chills, repeated shaking with chills, muscle pain, headache, sore throat and a loss of taste or smell.   Watch for symptoms People with COVID-19 have had a wide range of symptoms reported – ranging from mild symptoms to severe illness. Symptoms may appear 2-14 days after exposure to the virus. People with these symptoms or combinations of symptoms may have COVID-19: Cough Shortness of breath or difficulty breathing Or at least two of these symptoms: Fever Chills Repeated shaking with chills Muscle pain…
Read More

Alzheimer’s disease, clinical trials, & COVID-19: Q&A with Dr. Daniel Gillen

By Commentary, Community Events, COVID-19
Alzheimer's disease, clinical trials, and COVID-19 Join UCI MIND for a live Q&A on Facebook with Dr. Daniel Gillen, Professor and Chair of Statistics at UC Irvine, this Friday, May 1st at 11:00-11:30 AM PST. About the Speaker: Daniel Gillen received his PhD in Biostatistics from the University of Washington and leads the Data Management and Statistics Core for UCI MIND’s NIH-designated Alzheimer’s Disease Research Center. He is an elected fellow of the American Statistical Association and widely recognized for his work in the design and analysis of clinical trials for Alzheimer’s disease and other health conditions. Dr. Gillen serves…
Read More

VIDEO: Laboratory Research Update – Nicole Schartz, PhD

By Commentary, COVID-19, In the News
https://youtu.be/r4ZpVGrBw5o Nicole Schartz, PhD, a postdoctoral scholar in Dr. Andrea Tenner’s lab, shares her experience of what’s happening in her lab and her perspective on the pandemic.  Dr. Schartz is also a member of REMIND. Research and Education in Memory Impairments and Neurological Disorders, or REMIND, is a campus organization led by UCI MIND predoctoral and postdoctoral trainees. It aims to encourage collaboration among the next generation of scientists and clinicians, and promote community outreach and education on neurodegenerative diseases.
Read More

Don’t Feel Bad If Your Kids Are Gaming More Than Ever. In Fact, Why Not Join Them?

By Carousel Slider, Commentary, COVID-19, In the News
While doing a video interview with TIME, Craig Stark, professor at the University of California, Irvine’s Center for the Neurobiology of Learning and Memory, said that his eighth grade son was on a headset chatting with his friends while gaming. “I’m great with that,” says Stark. Still, he adds, “if you’re gaming 20 hours a day, let’s get out, let’s do some other stuff, let’s not just talk to each other on a screen. But in terms of the notion that video games are actively rotting the brain? No, I don’t see any evidence for that.”
Read More

UCI and UCI Health launch comprehensive COVID-19 resource site

By Commentary, COVID-19, In the News
The UCI Health Affairs Vice Chancellor is delighted to announce the launch of OC-COVID19.org, a new website devoted to providing timely, useful, evidence-based information about the novel coronavirus pandemic to our friends and neighbors across Orange County. UCI and UCI Health are at the forefront of Orange County's response to this national emergency. Every day there are stunning examples of remarkable, cutting-edge clinical care provided by the UCI Health family. Our services are driven by innovation and research taking place across the university. In this way, the UCI community is leading the way to solutions that are local and global.…
Read More